Global Health Limited reported a robust performance for the fiscal year 2026, with total income rising 20% year-on-year to INR 45,089 million. The company saw a 15.1% increase in consolidated profit after tax to INR 5,541 million. Driven by the successful ramp-up of the 550-bed Noida facility and sustained growth across its network, the company continues to invest in clinical capacity and strategic expansion projects to solidify its medium-term growth trajectory.
Annual Financial Performance
Global Health Limited (Medanta) achieved significant financial milestones in FY26. The company’s total income reached INR 45,089 million, representing a 20% year-on-year growth. Consolidated profit after tax grew to INR 5,541 million, an increase of 15.1% compared to the previous year. The Board of Directors has recommended a final dividend of INR 0.50 per share, reflecting 25% of the face value.
Operational Milestones and Noida Ramp-up
The 550-bed Noida facility, inaugurated in November 2025, has emerged as a key strategic asset. By the end of the year, it operationalized 382 beds, 98 ICU beds, and 14 operating theaters, securing NABH accreditation within six months. While the facility recorded an EBITDA loss of INR 783 million during FY26, the quarterly loss trend showed a significant reduction, dropping from INR 320 million in Q3 to INR 236 million in Q4.
Network Capacity and Clinical Growth
The total bed capacity across the network increased by 20.5% during the year, with 623 new beds added. Operational efficiency saw steady improvement, with the average length of stay (ALOS) decreasing by 4% to 3.04 days. Inpatient and outpatient counts grew by 16% and 19% respectively. The company also strengthened its clinical leadership by onboarding over 550 doctors, including 200 senior clinicians.
Strategic Expansion Projects
Looking ahead, Medanta plans to continue its aggressive expansion. The company has announced a 400-bed multi-specialty project in Varanasi and recently acquired an 80-bed hospital in Indore to enhance oncology capabilities. With a strong net cash position of INR 5,906 million, management has outlined a capital expenditure plan of INR 800 to 900 crore for FY27 to support these greenfield and brownfield initiatives.
Source: BSE
